APLP2 Protein, Human, Recombinant (His)

Amyloid β precursor-like protein 2 (APLP2) has been determined to serve an important role in the progression of a number of cancer types. APLP2 expression was significantly associated with disease-specific survival (P<0.001). APLP2 may be used to potentially predict patient prognosis, and to guide clinical diagnosis and treatment in CCRCC.

规格	价格/CNY		数量
100 μg	￥ 2,510	5日内发货
500 μg	￥ 10,000	5日内发货
1 mg	￥ 16,800	5日内发货

规格

价格/CNY

货期

数量

100 μg

￥ 2,510

5日内发货

500 μg

￥ 10,000

5日内发货

1 mg

￥ 16,800

5日内发货

产品描述

种属	Human
表达系统	HEK293
标签	C-His
蛋白编号	Q06481-1
别名	APPL2, YWK-II, APPH, CDEI box-binding, CDEBP
蛋白构建	Recombinant Human APLP2 Protein is expressed from HEK293 with His tag at the C-Terminus. It contains Gly32-Ser692.[Accession \|Q06481-1]
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
分子量	The protein has a predicted MW of 77.16 kDa. Due to glycosylation, the protein migrates to 85-100 kDa based on Tris-Bis PAGE result.

内毒素	Less than 1EU per μg by the LAL method.
缓冲液	Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
复溶方法	Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
存储	-20 to -80°C for 12 months as supplied from date of receipt. -20 to -80°C for 3-6 months in unopened state after reconstitution. 2-8°C for 2-7 days after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
运输方式	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
研究背景	Amyloid β precursor-like protein 2 (APLP2) has been determined to serve an important role in the progression of a number of cancer types. APLP2 expression was significantly associated with disease-specific survival (P<0.001). APLP2 may be used to potentially predict patient prognosis, and to guide clinical diagnosis and treatment in CCRCC.